 Kintara Therapeutics NASDAQ:KTRA Inc has announced that its chairman, Robert Hoffman, has succeeded Saiid Zarrabian as the companys president and CEO effective November 8, 2021. Kintara said Hoffman will continue in his role as the companys chairman, while Zarrabian will transition to lead Kintaras strategic partnerships initiative and will remain a member of its board of directors. 